These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Corticosteroid therapy for chronic obstructive pulmonary disease. Is it worth the risks? Alberts WM; Corrigan KC Postgrad Med; 1987 Apr; 81(5):131-4, 137. PubMed ID: 3550768 [TBL] [Abstract][Full Text] [Related]
44. [Staged therapy of chronic obstructive respiratory tract diseases. Treatment of chronic obstructive respiratory tract diseases by the established physician]. Hausen T Fortschr Med; 1989 Mar; 107(9):210-3. PubMed ID: 2566567 [No Abstract] [Full Text] [Related]
45. [Combined corticosteroid and synthetic depot ACTH therapy in chronic obstructive ventilation disorders]. Cegla UH; Demisch K Verh Dtsch Ges Inn Med; 1973; 79():891-4. PubMed ID: 4364059 [No Abstract] [Full Text] [Related]
46. Cutaneous alternaria infection in a patient on chronic corticosteroids. Sneeringer RM; Haas DW J Tenn Med Assoc; 1990 Jan; 83(1):15-7. PubMed ID: 2403614 [TBL] [Abstract][Full Text] [Related]
47. [The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive lung disease (COPD)]. van Schayck CP; Postma DS; Lammers JW Ned Tijdschr Geneeskd; 1999 Jan; 143(3):137-40. PubMed ID: 10086126 [TBL] [Abstract][Full Text] [Related]
48. Inflammometry to assess airway diseases. Pavord ID; Shaw DE; Gibson PG; Taylor DR Lancet; 2008 Sep; 372(9643):1017-9. PubMed ID: 18805315 [No Abstract] [Full Text] [Related]
49. [Indications for corticotherapy in stable COPD]. el Kamel A; Battikh M; Rouetbi N; Knani J Tunis Med; 1996 Dec; 74(12):563-8. PubMed ID: 9506060 [No Abstract] [Full Text] [Related]
50. [Inflammatory mediators in the pathogenesis of obstructive bronchial diseases: consequences for therapy]. Hahn HL Verh Dtsch Ges Inn Med; 1988; 94():364-75. PubMed ID: 2905102 [No Abstract] [Full Text] [Related]
51. [Inhalable corticosteroids in long-term COPD treatment. Opinions of an expert panel]. Gillissen A; Barczok M; Buhl R; Kardos P; Magnussen H; Matthys H; Rabe KF; Rothe T; Russi EW; Schauer J; Schmitz M; Vogelmeier C; Wettengel R; Worth H; Menz G Pneumologie; 2000 Jun; 54(6):256-62. PubMed ID: 10934897 [No Abstract] [Full Text] [Related]
52. Steroidphobia and the pulmonary patient. Della Bella LA Am J Nurs; 1992 Feb; 92(2):26-9. PubMed ID: 1739111 [No Abstract] [Full Text] [Related]
53. Special problems in respiratory diseases. Williams MH Geriatrics; 1974 Jun; 29(6):67-71. PubMed ID: 4831396 [No Abstract] [Full Text] [Related]
55. [Practical performance of corticoid-therapy in diseases of the respiratory tract (author's transl)]. Schmidt OP Med Klin; 1973 Dec; 68(49):1622-30. PubMed ID: 4204454 [No Abstract] [Full Text] [Related]
56. Developments in the treatment of chronic obstructive pulmonary disease: the clinical picture. Chavannes NH; van Schayck CP Curr Opin Investig Drugs; 2000 Sep; 1(1):75-8. PubMed ID: 11249599 [No Abstract] [Full Text] [Related]
57. Report from the 8th European Respiratory Society Annual Congress, Geneva, Switzerland, September 1998. Wroe CD Int J Clin Pract; 1998; 52(8):582-3. PubMed ID: 10660361 [No Abstract] [Full Text] [Related]
58. [Current approaches to the treatment of chronic obstructive pulmonary diseases]. Leshchenko IV; Ovcharenko SI Ter Arkh; 2003; 75(8):83-7. PubMed ID: 14520861 [No Abstract] [Full Text] [Related]
59. [Phlebothromboses as complications of long-term corticoid therapy in chronic-obstructive lung diseases]. Kirsten D; Sedlarik K; Meister W Z Arztl Fortbild (Jena); 1979 May; 73(9):428-30. PubMed ID: 483885 [No Abstract] [Full Text] [Related]